Belgian Center for Pharmacotherapeutic Information

What Belgian Center for Pharmacotherapeutic Information does

The Belgian Center for Pharmacotherapeutic Information (BCFI in Dutch, CBIP in French) is an independent non-profit association founded in 1971 and headquartered in Brussels, Belgium. It provides objective, evidence-based pharmacotherapeutic information to Belgian healthcare professionals — physicians, pharmacists, nurses, and elderly care facilities — to support rational prescribing, dispensing, and continuing medical education. The organization's core product is the Gecommentarieerd Geneesmiddelenrepertorium (Commentated Drug Repertory), a comprehensive monographed drug database organized by therapeutic chapter, supplemented by the Folia newsletter, the free accredited Auditorium e-learning platform, the Formularium 80+ for elderly prescribing, the Toolbox of clinical decision aids, and the BAPCOC-gids for anti-infective treatment. The underlying technology layer includes the EMD-databank, ATC-tabel, and VOS-tabel made available as monthly-updated SQL/CSV downloads for software developers, and iOS/Android mobile applications.

Name

Belgian Center for Pharmacotherapeutic Information

Legal name

Belgian Center for Pharmacotherapeutic Information

Website

https://bcfi.be

Company type

Private

Founded year

1971

Operating status

Operating

Headcount range

11–50 employees

Short description

The Belgian Center for Pharmacotherapeutic Information (BCFI/CBIP) is an independent, non-profit association founded in 1971 that provides evidence-based drug information, repertorium, newsletters, and accredited e-learning to Belgian physicians, pharmacists, and nurses.

Ownership category

akta.pro rank

Product category

Pharmacotherapy Information Services

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

akta.pro secondary industries

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC), Medical Writing & Clinical Documentation FSP (HLAGAOAC)

Keywords

• Drug information services
• Pharmacotherapy guidance
• Clinical decision support
• Evidence-based medicine
• Continuing medical education

Headquarters

HQ city

Brussels

HQ country

Belgium

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Others

Revenue model

1. Public Information Services: The BCFI provides independent, objective, evidence-based drug information to Belgian healthcare providers. The organization appears to be government-supported as it collaborates extensively with Belgian health authorities (FAGG, RIZIV, FOD Volksgezondheid). Core services including the Repertorium, Folia newsletters, Auditorium e-learnings, and tools appear to be freely accessible.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

The BCFI (Belgian Center for Pharmacotherapeutic Information) is an independent non-profit drug information center that publishes the Gecommentarieerd Geneesmiddelenrepertorium (annotated drug repertory), Folia newsletters, and the BAPCOC anti-infective guidelines for Belgian healthcare providers. It supplements these core publications with the Auditorium e-learning platform, the Formularium 80+ for elderly prescribing, a clinical Toolbox, weekly knowledge questions, and a mobile application, while distributing the underlying data as downloadable SQL/CSV databases for healthcare software integration.

Product overview

The Belgian Center for Pharmacotherapeutic Information (BCFI/CBIP) operates a comprehensive pharmacotherapeutic information system consisting of the core Repertorium (annotated drug database), the Folia news publication, Auditorium e-learning platform, and specialized modules including Formularium Ouderenzorg (elderly medication), Toolbox (clinical tools), Vraag van de Week (weekly quiz), BAPCOC-gids (antimicrobial guidelines), and MedicatieQuiz. The organization also provides developer-oriented data products (EMD-databank, ATC-tabel, VOS-tabel) in SQL/CSV formats for healthcare software integration, a mobile app for iOS/Android, and archived PDF repertoire editions dating to 2005. Specialty publications include Folia Tandartsen (dental) and Folia Nursing, along with a veterinary medicines compendium.

Differentiator

Problem solved

Functional benefit

Brands

• Repertorium: Gecommentarieerd Geneesmiddelenrepertorium - Commentated Drug Repertory providing independent drug information
• Folia
• Auditorium
• Formularium 80+
• BAPCOC-gids
• Vraag van de week
• VetCompendium

Products and services

• Repertorium (Gecommentarieerd Geneesmiddelenrepertorium)

Quantifiable outcome

• The BCFI provides guidance on approximately 1.26 billion EUR in annual RIZIV drug expenditures through its TOP 25 analysis and prescribing recommendations.
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature5 records

Partnerships

Nine partnerships are on record, tiered core.

• FAGG (Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten)coreStrategic or Co-development PartnerFAGG is the Belgian Medicines Agency. BCFI collaborates with FAGG on pharmacovigilance activities, including the black triangle symbol for medicines under additional monitoring and reporting of suspected adverse effects.
• RIZIV (Rijksinstituut voor Ziekte- en Invaliditeitsverzekering)coreStrategic or Co-development PartnerRIZIV is the National Institute for Health and Disability Insurance. BCFI analyzes RIZIV drug expenditure data (TOP 25) and provides recommendations for rational prescribing to support healthcare cost containment.
• FOD Volksgezondheid (Federal Public Service Health)coreStrategic or Co-development PartnerFederal Public Service for Health. BCFI works with FOD Volksgezondheid as part of the SAM (Authentieke Bron Geneesmiddelen) initiative to establish the reference database for medicines in Belgium.
• FOD Economie (Federal Public Service Economy)coreStrategic or Co-development PartnerFederal Public Service for Economy. Partner in the SAM (Authentieke Bron Geneesmiddelen) project for the reference database on medicines.
• APB (Algemene Pharmaceutische Bond)coreStrategic or Co-development PartnerAssociation of Pharmacies in Belgium. Partner in the SAM project for the reference database on medicines.
• eHealthcoreTechnology or IntegrationBelgian eHealth platform. Partner in the SAM project for establishing the reference database on medicines accessible to healthcare IT systems.
• SmalscoreTechnology or IntegrationIT organization for social security and healthcare. Partner in the SAM project for the reference database on medicines.
• BAPCOC (Belgian Commission for the Coordination of Antibiotic Policy)coreStrategic or Co-development PartnerBAPCOC publishes the Belgian guide for anti-infective treatment in ambulatory practice. The BCFI integrates BAPCOC guidelines (chapter 11.5) into the Repertorium and provides updates on guideline revisions through Folia articles. The 2026 edition was published in June 2026.
• SAM (Authentieke Bron Geneesmiddelen)coreStrategic or Co-development PartnerSAM is the reference database for medicines being developed by Belgian health authorities. BCFI is working with FAGG, RIZIV, FOD Volksgezondheid, FOD Economie, APB, eHealth, and Smals to transition from the EMD-databank to SAM.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Regional players

• CEBAM (Belgian Centre for Evidence-Based Medicine): Belgian reference centre for evidence-based medicine supporting guideline development and methodological quality; adjacent peer working in the same Belgian healthcare information space.
• KCE (Belgian Health Care Knowledge Centre): Belgian federal research centre producing health technology assessments and clinical guidelines; complementary rather than competing with BCFI, but operates in the same Belgian evidence ecosystem.

Direct peers

• Rote Liste: German comprehensive drug reference compendium widely used by German healthcare professionals; comparable in role to BCFI's Repertorium within the German market.
• Vidal: France's principal drug reference database covering monographs, interactions and prescribing guidance; a commercial equivalent of BCFI's Repertorium in the French-speaking market.
• Prescrire: French independent drug bulletin providing evidence-based, conflict-of-interest-free pharmacotherapy information to healthcare professionals — directly analogous to BCFI's mission and editorial model, but serving the French market.
• Drug and Therapeutics Bulletin: UK-based independent drug information publication (published by BMJ) delivering evidence-based reviews for prescribers; structurally similar to BCFI's Repertorium and Folia content.
• The Medical Letter: US independent, peer-reviewed publication providing objective drug evaluations and prescribing guidance; matches BCFI's positioning as an industry-independent therapeutic reference.
• NPS MedicineWise / Australian Prescriber: Australian independent organization providing evidence-based prescribing information, therapeutic guidelines and continuing education to clinicians — a direct functional analog of BCFI in a different geography.

Broad incumbents

• NICE (National Institute for Health and Care Excellence): UK national authority producing evidence-based clinical guidelines, prescribing guidance and CME-linked content; broader incumbent with a comparable regulatory-aligned, evidence-based information mission to BCFI.
• Wolters Kluwer Clinical Drug Information (Lexicomp): Global commercial provider of integrated drug information (Lexicomp, Medi-Span) embedded in EHR and pharmacy systems; a broader incumbent offering overlapping drug database functionality at international scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/BcfiCbip
• Facebookfacebook.com/BCFiNL
• LinkedInlinkedin.com/company/bcfi-cbip

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Belgian Center for Pharmacotherapeutic Information